Published in Int Immunopharmacol on May 20, 2015
Molecular Mechanisms Regulating LPS-Induced Inflammation in the Brain. Front Mol Neurosci (2016) 0.84
Carrier-free Gene Silencing by Amphiphilic Nucleic Acid Conjugates in Differentiated Intestinal Cells. Mol Ther Nucleic Acids (2016) 0.75
Ameliorating Active Ulcerative Colitis via an Orally Available Toll-Like Receptor-9 Modifier: A Prospective Open-Label, Multicenter Phase II Trial. Dig Dis Sci (2016) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Regulation and function of NF-kappaB transcription factors in the immune system. Annu Rev Immunol (2009) 11.76
Origin and physiological roles of inflammation. Nature (2008) 11.68
The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol (2004) 10.85
The inflammatory reflex. Nature (2002) 9.10
Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity (2008) 5.82
Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov (2006) 5.19
Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol (2005) 4.30
Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK. Nat Immunol (2008) 3.91
Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol (2006) 3.16
Acetylcholinesterase--new roles for an old actor. Nat Rev Neurosci (2001) 2.87
IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol (2007) 2.44
MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase. Immunity (2009) 2.33
Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev (2007) 2.22
IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9. Nature (2006) 2.16
Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc Natl Acad Sci U S A (2008) 2.05
Genetic predisposition to adverse consequences of anti-cholinesterases in 'atypical' BCHE carriers. Nat Med (1995) 1.87
The vagus nerve and the inflammatory reflex--linking immunity and metabolism. Nat Rev Endocrinol (2012) 1.59
MicroRNA modulation of megakaryoblast fate involves cholinergic signaling. Leuk Res (2005) 1.49
Noncanonical NF-kappaB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood (2007) 1.42
Alternative splicing and neuritic mRNA translocation under long-term neuronal hypersensitivity. Science (2002) 1.39
Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis (2012) 1.24
Combinatorial complexity of 5' alternative acetylcholinesterase transcripts and protein products. J Biol Chem (2004) 1.20
Stress-induced epigenetic transcriptional memory of acetylcholinesterase by HDAC4. Proc Natl Acad Sci U S A (2012) 1.16
Acetylcholinesterase inhibitors reduce brain and blood interleukin-1beta production. Ann Neurol (2005) 1.05
Post-traumatic anxiety associates with failure of the innate immune receptor TLR9 to evade the pro-inflammatory NFκB pathway. Transl Psychiatry (2012) 0.99
Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells. Eur J Immunol (2008) 0.98
MicroRNA-132 modulates cholinergic signaling and inflammation in human inflammatory bowel disease. Inflamm Bowel Dis (2013) 0.97
Predicted overlapping microRNA regulators of acetylcholine packaging and degradation in neuroinflammation-related disorders. Front Mol Neurosci (2014) 0.96
Hydrolytic and nonenzymatic functions of acetylcholinesterase comodulate hemopoietic stress responses. J Immunol (2006) 0.93
RNA-targeted suppression of stress-induced allostasis in primate spinal cord neurons. Neurodegener Dis (2005) 0.89
Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. PLoS One (2011) 0.89
Antisense treatment for myasthenia gravis: experience with monarsen. Ann N Y Acad Sci (2008) 0.88
AChE and RACK1 promote the anti-inflammatory properties of fluoxetine. J Mol Neurosci (2013) 0.87
Stress-induced cholinergic signaling promotes inflammation-associated thrombopoiesis. Blood (2005) 0.87
The thymic theme of acetylcholinesterase splice variants in myasthenia gravis. Blood (2007) 0.86
Coding region paraoxonase polymorphisms dictate accentuated neuronal reactions in chronic, sub-threshold pesticide exposure. FASEB J (2006) 0.84
Neuromuscular therapeutics by RNA-targeted suppression of ACHE gene expression. Ann N Y Acad Sci (2006) 0.80